Methylamine: A new endogenous modulator of neuron firing?

Medical Science Monitor

Volumn 11, Issue 8, 2005, Pages

  Pirisino, Renato ^a   Ghelardini, Carla ^a   De Siena, Gaetano ^a   Malmberg, Petra ^a   Galeotti, Nicoletta ^a   Cioni, Laura ^a   Banchelli, Grazia ^a   Raimondi, Laura ^a,b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Dept of Pharmacology ^*  (Italy)

Author keywords

Ammonia; Hypophagia; Methylamine; Nitric oxide; Potassium channels; Semicarbazide senstitive amine oxidase activity

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); AMINOGUANIDINE; AMMONIA; FORMALDEHYDE; HYDROGEN PEROXIDE; METHYLAMINE; VOLTAGE GATED POTASSIUM CHANNEL;

CATABOLISM; DEAMINATION; DEGENERATIVE DISEASE; DIABETES MELLITUS; EATING DISORDER; FOOD INTAKE; HYPOPHAGIA; HYPOTHALAMUS; NERVE CONDUCTION; NEUROTRANSMITTER RELEASE; NONHUMAN; OBESITY; REVIEW;

ANIMALS; CENTRAL NERVOUS SYSTEM; HUMANS; METHYLAMINES; NEURONS; NITRIC OXIDE; OBESITY; POTASSIUM CHANNELS;

EID: 24044439477     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Raimondi L, Pirisino R, Ignesti G et al: A common distribution of the semicarbazide-sensitive amine oxidase activity (SSAO) in white adipose tissue (WAT). Pharmacol Res, 1992; 25(Suppl.1): 21-22
2. Lyles GA, Pino R: Properties and functions of tissue-bound semicarbazide-sensitive amine oxidases in isolated cell preparations and cell cultures. J Neural Transm Suppl, 1998; 52: 239-50
3. Meszaros Z, Szombathy T, Raimondi L et al: Elevated serum semicarbazide-sensitive amine oxidase activity in non-insulin-dependent diabetes mellitus: correlation with body mass index and serum triglyceride. Metabolism, 1999; 48(1): 113-17
4. Stolen CM, Yegutkin GG, Kurkijarvi R et al: Origins of Serum Semicarbazide-Sensitive Amine Oxidase. Circ Res, 2004; 01
5. Yu PH: Deamination of methylamine and angiopathy; toxicity of formaldehyde, oxidative stress and relevance to protein glycoxidation in diabetes. J Neural Transm Suppl, 1998; 52: 201-16
6. Yu PH, Wright S, Fan EH et al: Physiological and pathological implications of semicarbazide-sensitive amine oxidase. Biochim Biophys Acta, 2003; 1647(1-2): 193-99
7. Butterworth RF: Pathogenesis of hepatic encephalopathy: new insights from neuroimaging and molecular studies. J Hepatol, 2003; 39(2): 278-85
8. Mundorf ML, Hochstetler SE, Wightman RM: Amine weak bases disrupt vesicular storage and promote exocytosis in chromaffin cells. J Neurochem, 1999; 73(6): 2397-405
9. Szerb JC, Butterworth RF: Effect of ammonium ions on synaptic transmission in the mammalian central nervous system. Prog Neurobiol, 1992; 39(2): 135-53
10. Aguilar MA, Minarro J, Felipo V: Chronic moderate hyperammonemia impairs active and passive avoidance behavior and conditional discrimination learning in rats. Exp Neurol, 2000; 161(2): 704-13
11. Basile AS: Direct and indirect enhancement of GABAergic neurotransmission by ammonia: implications for the pathogenesis of hyperammonemic syndromes. Neurochem Int, 2002; 41(2-3): 115-22
12. + concentrations. Neurochem Int, 2002; 41(2-3): 87-93
13. Yu PH: Increase of formation of methylamine and formaldehyde in vivo after administration of nicotine and the potential cytotoxicity. Neurochem Res, 1998; 23(9): 1205-10
14. Lyles GA, McDougall SA: The enhanced daily excretion of urinary methylamine in rats treated with semicarbazide or hydralazine may be related to the inhibition of semicarbazide-sensitive amine oxidase activities. J Pharm Pharmacol, 1989; 41(2): 97-100
15. Simenhoff ML: Metabolism and toxicity of aliphatic amines. Kidney Int Suppl, 1975; (3): 314-17
16. Meszaros Z, Szombathy T, Raimondi L et al: Elevated serum semicarbazide-sensitive amine oxidase activity in non-insulin-dependent diabetes mellitus: correlation with body mass index and serum triglyceride. Metabolism, 1999; 48(1): 113-17
17. Conforti L, Pirisino R, Ignesti G et al: Semicarbazide-sensitive amine oxidase activity in white adipose tissue of the insulin-deficient rat. J Pharm Pharmacol, 1995; 47(5): 420-24
18. Stolen CM, Rami M, Luc M et al: Semicarbazide sensitive amine oxidase overexpression has dual consequences: insulin mimicry and diabetes-like complications. Faseb J, 2004; 18(6): 702-4
19. Morin N, Lizcano JM, Fontana E et al: Semicarbazide-sensitive amine oxidase substrates stimulate glucose transport and inhibit lipolysis in human adipocytes. J Pharmacol Exp Ther, 2001; 297(2): 563-72
20. Pirisino R, Ghelardini C, Banchelli G et al: Methylamine and benzylamine induced hypophagia in mice: modulation by semicarbazide-sensitive benzylamine oxidase inhibitors and aODN towards Kv1.1 channels. Br J Pharmacol, 2001; 134(4): 880-86
21. Inui A: Transgenic approach to the study of body weight regulation. Pharmacol Rev, 2000; 52(1): 35-61
22. Banchelli G, Ghelardini C, Raimondi L et al: Selective inhibition of amine oxidases differently potentiate the hypophagic effect of benzylamine in mice. Eur J Pharmacol, 2001; 413(1): 91-99
23. + channel modulation on mouse feeding behaviour. Eur J Pharmacol, 1997; 329(1): 1-8
24. Lan S, Storlien LH, Huang XF: Leptin receptor, NPY, POMC mRNA expression in the diet-induced obese mouse brain. Brain Res, 2000; 875(1-2): 89-95
25. Mercier N, Moldes M, El Hadri K, Feve B: Regulation of semicarbazide-sensitive amine oxidase expression by tumor necrosis factor-alpha in adipocytes: functional consequences on glucose transport. J Pharmacol Exp Ther, 2003; 304(3): 1197-208
26. Rama Rao KV, Jayakumar AR, Norenberg DM: Ammonia neurotoxicity: role of the mitochondrial permeability transition. Metab Brain Dis, 2003; 18(2): 113-27
27. Simenhoff ML: Metabolism and toxicity of aliphatic amines. Kidney Int Suppl, 1975; (3): 314-17
28. Rama Rao KV, Jayakumar AR, Norenberg DM: Ammonia neurotoxicity: role of the mitochondrial permeability transition. Metab Brain Dis, 2003; 18(2): 113-27